Literature DB >> 34612774

Mortality in hospitalized COVID-19 patients was associated with the COVID-19 admission rate during the first year of the pandemic in Sweden.

Kristoffer Strålin1,2,3, Erik Wahlström4, Sten Walther5,6,7, Anna M Bennet-Bark4, Mona Heurgren4, Thomas Lindén8, Johanna Holm4, Håkan Hanberger9,10.   

Abstract

INTRODUCTION: Studies from the first pandemic wave found associations between COVID-19 hospital load and mortality. Here, we aimed to study if mortality of hospitalized COVID-19 patients was associated with the COVID-19 admission rate during a full year of the pandemic in Sweden.
METHOD: Observational review of all patients admitted to hospital with COVID-19 in Sweden between March 2020 and February 2021 (n = 42,017). Primary outcome was 60-day all-cause mortality related to number of COVID-19 hospital admissions per month/100,000 inhabitants. Poisson regression was used to estimate the relative risk for death by month of admission, adjusting for pre-existing factors.
RESULTS: The overall mortality was 17.4%. Excluding March 2020, mortality was clearly correlated to the number of COVID-19 admissions per month (coefficient of correlation ρ=.96; p<.0001). After adjustment for pre-existing factors, the correlation remained significant (ρ=.75, p=.02). Patients admitted in December (high admission rate and high mortality) had more comorbidities and longer hospital stays, and patients treated in intensive care units (ICU) had longer pre-ICU hospital stays and worse respiratory status on ICU admission than those admitted in July to September (low admission rate and low mortality).
CONCLUSION: Mortality in hospitalized COVID-19 patients was clearly associated with the COVID-19 admission rate. Admission of healthier patients between pandemic waves and delayed ICU care during wave peaks could contribute to this pattern. The study supports measures to flatten-the-curve to reduce the number of COVID-19 patients admitted to hospital.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; Sweden; mortality; nationwide

Mesh:

Year:  2021        PMID: 34612774     DOI: 10.1080/23744235.2021.1983643

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  3 in total

1.  Age-Dependent Biomarkers for Prediction of In-Hospital Mortality in COVID-19 Patients.

Authors:  Eugene Feigin; Tal Levinson; Asaf Wasserman; Shani Shenhar-Tsarfaty; Shlomo Berliner; Tomer Ziv-Baran
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

2.  Re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93: Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients.

Authors:  Carlos G Wambier; Gerard J Nau
Journal:  Eur Urol       Date:  2022-02-23       Impact factor: 24.267

3.  COVID-19 pandemic in Southern Brazil: Hospitalizations, intensive care unit admissions, lethality rates, and length of stay between March 2020 and April 2022.

Authors:  Jonas Michel Wolf; Helena Petek; Juçara G Maccari; Luiz Antonio Nasi
Journal:  J Med Virol       Date:  2022-06-23       Impact factor: 20.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.